P454The cannabinoid receptor type two is a therapeutic target for muscular dystrophy cardiomyopathy. (23rd April 2018) - Gowran, A; Castiglioni, E; Rovina, D; Casalnuovo, F; Nigro, P; Spinelli, P; Visone, R; Rasponi, M; Redaelli, A; Pompilio, G